CKD patients on hemodialysis who were supplemented with omega-3 fatty acids had significantly lower levels of CRP, IL-6, TNF-alpha, and IL-10/IL-6 ratio, reducing cardiovascular risk (37). The gene discussed is CRP; the disease is chronic kidney disease.